Outcomes and prediction of lethal recurrence after transoral robotic surgery for HPV+ head and neck cancer.
Devraj Basu(University of Pennsylvania), Robert M. Brody(University of Pennsylvania), Samuel Swisher‐McClure(University of Pennsylvania), Steven B. Cannady(University of Pennsylvania), Umamaheswar Duvvuri(City University of New York), Christopher H. Rassekh(University of Pennsylvania), Charu Aggarwal(UPMC Hillman Cancer Center), Bert W. O’Malley(Baylor College of Medicine), Lee Hartner(Illinois CancerCare), Joshua Bauml(University of Pennsylvania), Alexander Lin(University of Pennsylvania Health System), Jason G. Newman(University of Pennsylvania), David Shimunov(University of Pennsylvania), Karthik Rajasekaran(University of Pennsylvania), Gregory S. Weinstein(University of Pennsylvania), Roger B. Cohen(University of Pennsylvania), John N. Lukens(Radiation Oncology Associates), Ara A. Chalian(University of Pennsylvania), Phyllis A. Gimotty(University of Pennsylvania)
Cited by 2
Related Papers
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice
|Science|2018|1.5k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
|Journal of the National Comprehensive Cancer Network|2019|1k